Herbert J Faleck
CIK 1652994 · View on SEC EDGAR ↗
First SEC filing: Sept. 30, 2015 · Latest: Sept. 30, 2015
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 6, 2015 | PDSB | P | 500 | $11.00 | $5,500 | 500 Direct | — | Acquired | -99.9% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 14, 2018 | PDSB | Restricted Stock Units | Common Stock (59,833) | — | — | 59,833 | Acquired |
| June 19, 2018 | PDSB | Stock Option (Right To Purchase) | Common Stock (119,667) | $1.10 | — | 119,667 | Acquired |
| March 1, 2018 | PDSB | Stock Option (Right To Purchase) | Common Stock (90,000) | $14.98 | March 1, 2028 | 90,000 | Acquired |
| Jan. 2, 2018 | PDSB | Stock Option (Right To Purchase) | Common Stock (50,000) | $10.10 | Jan. 2, 2028 | 50,000 | Acquired |
| March 13, 2017 | PDSB | Stock Option (right To Purchase) | Common Stock (110,000) | $8.86 | March 13, 2027 | 110,000 | Acquired |
| March 1, 2016 | PDSB | Stock Option (right To Purchase) | Common Stock (25,000) | $7.24 | March 1, 2026 | 25,000 | Acquired |
| Feb. 16, 2016 | PDSB | Stock Option (Right to Purchase) | Common Stock (110,000) | $6.99 | Feb. 16, 2026 | 110,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PDSB
Chief Medical Officer(4)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $416,000 | $187,200 | — | — | — | — | $11,000 | $1,312,063 |
| 2017 | $400,000 | — | — | $724,493 | $153,000 | — | $10,800 | $1,288,293 |
| 2016 | $337,100 | — | — | $653,933 | $150,840 | — | — | $1,141,873 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.